Kleem Chaudhary
Corporate Officer/Principal chez CHECKMATE PHARMACEUTICALS, INC.
Postes actifs de Kleem Chaudhary
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2019 | - |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Directeur des opérations | - | - |
Historique de carrière de Kleem Chaudhary
Anciens postes connus de Kleem Chaudhary
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/02/2018 | 01/10/2019 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/05/2016 | 01/01/2018 |
| NOVARTIS AG | Corporate Officer/Principal | 01/04/2009 | 01/05/2016 |
Formation de Kleem Chaudhary
| The University of Winnipeg | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Japon | 2 |
| Suisse | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Health Technology |
- Bourse
- Insiders
- Kleem Chaudhary
- Expérience
